Tevogen TVGN
NASDAQ TVGN
$5.33 -0.39 (-6.82%)
At close: Nov 13, 2026 · 4:00 PM EST

Tevogen (TVGN) Net Long-Term Debt Issued (Repaid) (2023 - 2026)

Updated

Tevogen (TVGN) recorded Non-Current Debt of $6.4 million in Q2 2026, up 45.5% from $4.4 million a year earlier and unchanged from the prior quarter.

Analysis

Tevogen (TVGN) Net Long-Term Debt Issued (Repaid) (2023 - 2026) Analysis & Trends

At the end of FY2025, Tevogen reported Non-Current Debt of $4.4 million, up 340.0% from FY2024.

  • Across earlier years, Non-Current Debt came in at $1 million in FY2024.
  • On a year-over-year basis, Non-Current Debt has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $6.4 million (Q1 2026), $4.4 million (Q4 2025) and $4.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -1.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.98 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Tevogen 22.68 Mn 19.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Dec 31, 2025 -3.40 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 3.90 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2023 350,000.00
Sep 30, 2023 1.15 Mn
Mar 31, 2023 2.50 Mn
API Access

Tevogen Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TVGN&period=max&api_key=YOUR_API_KEY